Personal Mobility Devices Market (By Product: Walking Aids, Wheelchairs, Scooters) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Personal Mobility Devices Market
5.1. COVID-19 Landscape: Personal Mobility Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Personal Mobility Devices Market, By Product
8.1. Personal Mobility Devices Market Revenue and Volume, by Product, 2024-2033
8.1.1. Walking Aids
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Wheelchairs
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Scooters
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Personal Mobility Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.1.2. U.S.
9.1.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.2.2. UK
9.2.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.2.3. Germany
9.2.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.2.4. France
9.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.3.2. India
9.3.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.3.3. China
9.3.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.3.4. Japan
9.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.4.2. GCC
9.4.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.4.3. North Africa
9.4.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.4.4. South Africa
9.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.5.2. Brazil
9.5.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
Chapter 10. Company Profiles
10.1. Invacare Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Pride Mobility
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Kaye products
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Briggs Healthcare
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Carex Health brand
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. GF Health products
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Ottobock
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Permobil
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Electric mobility
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Euroverma
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample